About Nanomedicine

This section aims at explaing what is nanomedicine, which medical applications are targeted, what are the benefits from using nanotechnologies in these fields and how the European research community is structured to support Nanomedicine.

What is Nanomedicine?

Explaining nanomedicine with a two minutes animated video


The ETPN together with the NANOMED2020 consortium created a two minutes animated movie explaining in simple terms what is nanomedicine to the general public and what are the major fields of applications.


VIEW the Animated video by clicking on the picture above.

THE POTENTIAL OF NANOMEDICINE: Why is small different?



At the nano-scale, the surface-to-volume ratio is such that the surface properties are becoming an intrinsic parameter of the potential actions of a particle or material. Coating of the particles and functionalization of their surfaces (even on multiple levels) are in this way extremely common to increase the biocompatibility of the particle and its circulation time in the blood, as well as to ensure a highly selective binding to the desired target.


Nanomedicine has the potential to enable early detection and prevention and to drastically improve diagnosis, treatment and follow-up of many diseases including cancer but not only. Overall, Nanomedicine has nowadays more than 70 products under clinical trials, covering all major diseases including cardiovascular, neurodegenerative, musculoskeletal and inflammatory. Enabling technologies in all healthcare areas, Nanomedicine is already accounting for 77 marketed products, ranging from nano-delivery (44) and pharmaceutical (18) to imaging, diagnostics and biomaterial (15).


As any medical devices or drugs, nanomedicines are strictly regulated and have to follow thorough characterization, toxicity assessment and multi-stage clinical trials before benefiting patients with their whole potential.

Nanomedicine is understood to be a key enabling instrument for personalized, targeted and regenerative medicine by delivering the next level of new drugs, treatments and implantable devices to clinicians and patients, for real breakthroughs in healthcare.

Beyond that, Nanomedicine provides important new tools to deal with the grand challenge of an ageing population and is thought to be instrumental for improved and cost effective healthcare, one crucial factor for making medicines and treatments available and affordable to all.



Further readings:



Document Actions